ICYMI: Increase in drug-resistant superbugs during COVID-19 highlights need for policy reforms to address antimicrobial resistance

A newreport released by the U.S. Centers for Disease Control and Prevention (CDC) shows the number of antimicrobial-resistant (AMR) infections rose dramatically during the first year of the COVID-19 pandemic. After years of decline, these drug-resistant infections – often referred to as “superbugs” – caused a 15% increase in hospitalizations and deaths in 2020 alone. Antibiotic and antifungal medicines are critical to the everyday practice of medicine, yet many of our existing medicines may soon no longer be enough.
Source: The Catalyst - Category: Pharmaceuticals Tags: Research and Development Coronavirus Antimicrobial Resistance Source Type: news